Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Quotient added to Russell 2000, Russell 3000 Indexes » 08:19
07/01/20
07/01
08:19
07/01/20
08:19
QTNT

Quotient

$7.40 /

+0.405 (+5.79%)

Quotient Limited…

Quotient Limited announced that the Company has been added to the Russell 2000 and 3000 Indexes, effective June 29, 2020 as part of the 2020 Russell U.S. indexes reconstitution.

ShowHide Related Items >><<
QTNT Quotient
$7.40 /

+0.405 (+5.79%)

QTNT Quotient
$7.40 /

+0.405 (+5.79%)

05/18/20 Cowen
Quotient partner update suggests progress on antibody front, says Cowen
QTNT Quotient
$7.40 /

+0.405 (+5.79%)

  • 07
    Nov
QTNT Quotient
$7.40 /

+0.405 (+5.79%)

Over a month ago
Earnings
Quotient sees FY21 sales of Alba $32M-$34M compared to $31.6M in FY19 » 06:12
06/09/20
06/09
06:12
06/09/20
06:12
QTNT

Quotient

$6.62 /

+0.035 (+0.53%)

A forecast of COVID-19…

A forecast of COVID-19 antibody tests is not currently possible due to the uncertainties related to the development of this new market. No other revenues are expected. Sees FY20 Capital expenditures $5M-$10M; average monthly cash use for operations $5M-$6M excluding potential revenue related to COVID-19 antibody test. Sees Q1 Alba by Quotient product sales of $8.4M-$8.9M, compared with $8.2M for the Q1 of FY20. The company stated, "The Company is not providing guidance on the operating loss due to the uncertainty around revenues derived from MosaiQ by Quotient COVID-19 antibody tests. Quarterly product sales can fluctuate depending upon the shipment cycles for red blood cell-based products, which account for approximately two-thirds of current product sales. These products typically experience 13 shipment cycles per year, equating to three shipments of each product per quarter, except for one quarter per year when four shipments occur. The timing of shipment of bulk antisera products to OEM customers may also move revenues from quarter to quarter. Some seasonality in demand is also experienced around holiday periods in both Europe and the United States. As a result of these factors, Quotient expects to continue to see seasonality and quarter-to-quarter variations in product sales. The timing of product development fees included in other revenues is mostly dependent upon the achievement of pre-negotiated project milestones."

ShowHide Related Items >><<
QTNT Quotient
$6.62 /

+0.035 (+0.53%)

QTNT Quotient
$6.62 /

+0.035 (+0.53%)

05/18/20 Cowen
Quotient partner update suggests progress on antibody front, says Cowen
QTNT Quotient
$6.62 /

+0.035 (+0.53%)

QTNT Quotient
$6.62 /

+0.035 (+0.53%)

Earnings
Quotient reports Q4 EPS (31c), consensus (34c) » 06:07
06/09/20
06/09
06:07
06/09/20
06:07
QTNT

Quotient

$6.62 /

+0.035 (+0.53%)

Reports Q4 revenue $8.7M,…

Reports Q4 revenue $8.7M, consensus $7.93M. "The global coronavirus crisis was a shock to everyone, but we are very proud of how the Quotient team leveraged the knowledge we acquired over the past eight years, and the flexibility of the MosaiQ platform, to develop a state of the art COVID-19 antibody test. The test performs with 100% sensitivity and 99.8% specificity and detects antibodies early due to its sensitivity to both IgM and IgG antibodies. The fact that we were able to sign several MosaiQ COVID-19 antibody test customer contracts, demonstrates the attractiveness of our innovative MosaiQ platform," said Franz Walt, CEO of Quotient.

ShowHide Related Items >><<
QTNT Quotient
$6.62 /

+0.035 (+0.53%)

QTNT Quotient
$6.62 /

+0.035 (+0.53%)

05/18/20 Cowen
Quotient partner update suggests progress on antibody front, says Cowen
QTNT Quotient
$6.62 /

+0.035 (+0.53%)

QTNT Quotient
$6.62 /

+0.035 (+0.53%)

Recommendations
Quotient partner update suggests progress on antibody front, says Cowen » 13:08
05/18/20
05/18
13:08
05/18/20
13:08
QTNT

Quotient

$7.37 /

-0.04 (-0.54%)

Cowen analyst Joshua…

Cowen analyst Joshua Jennings made no change to his Outperform rating and $14 price target on Quotient shares after Open Orphan issued a statement indicating that MosaiQ is on site at its lab and is set to be fully operational within to weeks. Jennings tells investors in a research note that he continues to be encouraged by Quotient's progress in the EU for its antibody test and awaits receipt of an EUA from the FDA, which he expects "imminently."

ShowHide Related Items >><<
QTNT Quotient
$7.37 /

-0.04 (-0.54%)

QTNT Quotient
$7.37 /

-0.04 (-0.54%)

QTNT Quotient
$7.37 /

-0.04 (-0.54%)

Hot Stocks
Open Orphan issues comment regarding collaboration with Quotient Limited » 13:04
05/18/20
05/18
13:04
05/18/20
13:04
QTNT

Quotient

$7.28 /

-0.13 (-1.75%)

Open Orphan plc noted an…

Open Orphan plc noted an increase in the company's share price and media comment regarding its collaboration with Quotient Limited. Furthermore, it also notes the substantial increase in interest in antibody testing for Covid-19 following recent announcements by the UK Government. "The company confirms that the MosaiQ COVID-19 Antibody Microarray machine is on site at hVivo's laboratory in East London and is undergoing testing. It is expected to be fully operational within two weeks following which it will have capability to undertake up to 3,000 tests a day, in line with expected performance as stated by Quotient Limited. The company intends to enter into discussions with channel partners to secure testing volumes with pricing to be determined as part of these negotiations. It is not the company's intention to deal directly with consumers and while there can be no certainty on pricing until such time as terms are agreed, the company notes current market prices ranging from c.GBP 70 for home testing kits and upwards towards c.GBP 150. It is the intention to supply testing capability to channel partners, who will in turn deal with the end users and the final price points. The company will update shareholders in due course," Open Orphan stated. Reference Link

ShowHide Related Items >><<
QTNT Quotient
$7.28 /

-0.13 (-1.75%)

QTNT Quotient
$7.28 /

-0.13 (-1.75%)

QTNT Quotient
$7.28 /

-0.13 (-1.75%)

Hot Stocks
Quotient enters partnership with hVIVO » 05:25
05/11/20
05/11
05:25
05/11/20
05:25
QTNT

Quotient

$7.39 /

-0.1 (-1.34%)

Quotient and hVIVO, part…

Quotient and hVIVO, part of Open Orphan, announced that the MosaiQ by Quotient system and MosaiQ COVID-19 Antibody Microarray will be used by hVIVO to screen for SARS-CoV-2 antibodies (COVID-19). Quotient has entered into an exclusive contract with hVIVO, whereby Quotient is hVIVO's exclusive supplier of COVID-19 antibody testing equipment, to support COVID-19 antibody testing in the UK. hVIVO, based in London, UK, is a world leader in the testing of vaccines and antivirals using human challenge study models.

Hot Stocks
Quotient announces CE Mark for SARS-CoV-2 antibody microarray » 09:02
05/01/20
05/01
09:02
05/01/20
09:02
QTNT

Quotient

$9.26 /

+0.27 (+3.00%)

Quotient Limited…

Quotient Limited announced that it has completed the process for declaring conformity to the essential requirements of the In Vitro Diagnostics Directive and has CE marked its SARS-CoV-2 antibody microarray. The test is now available for sale in Europe and Switzerland. The MosaiQ COVID-19 Antibody Microarray is designed as a serological disease screen specific to COVID-19. The assay detects the IgG and IgM antibodies directed at SARS-CoV-2. In addition to the concordance studies, the Company observed seroconversions in two patients where diagnosis was supported by a polymerase chain reaction assay on the patients at the time of symptoms. In one patient, the antibody negative status changed to positive one day after the PCR positive result, and in another patient, the antibody negative status changed to positive four days post PCR result. This demonstrates that the MosaiQ antibody test can detect antibodies very early in seroconversion process. This the Company's fourth market clearance and the CE certification of the third Microarray within a year. The MosaiQ instrument is CE marked and the Company's microarray manufacturing facility is ISO 13485 certified.

On The Fly
Fly Intel: Pre-market Movers » 09:10
04/28/20
04/28
09:10
04/28/20
09:10
UPS

UPS

$102.57 /

+2.37 (+2.37%)

, MRK

Merck

$83.98 /

+2.55 (+3.13%)

, DGX

Quest Diagnostics

$116.13 /

+9.41 (+8.82%)

, QTNT

Quotient

$7.56 /

+1.07 (+16.49%)

, FFIV

F5 Networks

$130.95 /

+3.62 (+2.84%)

, HOG

Harley-Davidson

$18.91 /

+0.28 (+1.50%)

, BPMC

Blueprint Medicines

$70.84 /

+0.29 (+0.41%)

, SDC

SmileDirectClub

$5.40 /

+0.15 (+2.86%)

, PEP

PepsiCo

$134.48 /

+0.16 (+0.12%)

, MMM

3M

$153.67 /

+6.675 (+4.54%)

, CAT

Caterpillar

$115.28 /

+1.26 (+1.11%)

Check out this morning's…

Open Full Text

ShowHide Related Items >><<
UPS UPS
$102.57 /

+2.37 (+2.37%)

04/28/20 Roth Capital
Workhorse Group initiated with a Buy at Roth Capital
04/27/20 Citi
UPS share setup into Q1 report is not positive, says Citi
04/24/20 Oppenheimer
UPS price target lowered to $106 from $124 at Oppenheimer
04/17/20
Fly Intel: Top five analyst downgrades
MRK Merck
$83.98 /

+2.55 (+3.13%)

04/27/20 SVB Leerink
Clovis downgraded to Underperform at SVB Leerink as prostate opportunity fades
04/06/20 Raymond James
NGM Biopharmaceuticals initiated with a Strong Buy at Raymond James
03/23/20 Mizuho
Merck business disruptions have been modest, says Mizuho
03/02/20 William Blair
Merck results revive fears about Seattle Genetics' Adcetris, says William Blair
DGX Quest Diagnostics
$116.13 /

+9.41 (+8.82%)

04/28/20 Morgan Stanley
Morgan Stanley upgrades Quest Diagnostics to Overweight on COVID testing boost
04/28/20 Morgan Stanley
Quest Diagnostics upgraded to Overweight from Equal Weight at Morgan Stanley
04/27/20
Fly Intel: Top five analyst upgrades
04/27/20 Wolfe Research
Quest Diagnostics upgraded to Peer Perform from Underperform at Wolfe Research
QTNT Quotient
$7.56 /

+1.07 (+16.49%)

FFIV F5 Networks
$130.95 /

+3.62 (+2.84%)

04/28/20 Goldman Sachs
F5 Networks upgraded to Neutral from Sell at Goldman Sachs
04/28/20 JPMorgan
F5 Networks price target raised to $145 from $138 at JPMorgan
04/28/20 Credit Suisse
F5 Networks price target lowered to $151 from $156 at Credit Suisse
04/28/20 Nomura Instinet
F5 Networks price target raised to $165 from $145 at Nomura Instinet
HOG Harley-Davidson
$18.91 /

+0.28 (+1.50%)

04/23/20 BMO Capital
Harley-Davidson price target lowered to $20 from $37 at BMO Capital
04/06/20 Argus
Harley-Davidson downgraded to Hold from Buy at Argus
04/06/20 Argus
Harley-Davidson downgraded to Hold from Buy at Argus
03/24/20 Morgan Stanley
Morgan Stanley upgrades Auto industry rating to In-Line from Cautious
BPMC Blueprint Medicines
$70.84 /

+0.29 (+0.41%)

04/01/20 Piper Sandler
Piper Sandler prefers to stay on sidelines after Blueprint Medicines update
03/24/20 Wedbush
Blueprint Medicines added to Best Ideas List at Wedbush
03/17/20 SVB Leerink
Blueprint Medicines price target raised to $125 from $116 at SVB Leerink
03/17/20 Cowen
Blueprint Medicines PIONEER data a major step toward efficacy, says Cowen
SDC SmileDirectClub
$5.40 /

+0.15 (+2.86%)

04/07/20 Goldman Sachs
SmileDirectClub downgraded to Sell from Neutral at Goldman Sachs
04/06/20 Guggenheim
SmileDirectClub removed from Best Ideas list at Guggenheim
03/02/20
Fly Intel: Top five analyst downgrades
03/02/20 UBS
SmileDirectClub downgraded to Neutral from Buy at UBS
PEP PepsiCo
$134.48 /

+0.16 (+0.12%)

04/20/20 Morgan Stanley
Campbell Soup initiated with an Equal Weight at Morgan Stanley
04/01/20 Goldman Sachs
PepsiCo resumed a Conviction Buy at Goldman Sachs
03/27/20
Fly Intel: Top five analyst upgrades
03/27/20 Credit Suisse
Credit Suisse double upgrades 'high-quality asset' PepsiCo to Outperform
MMM 3M
$153.67 /

+6.675 (+4.54%)

03/30/20
Fly Intel: Top five analyst downgrades
03/30/20 Gordon Haskett
3M downgraded to Underperform from Hold at Gordon Haskett
01/09/20 Wolfe Research
3M upgraded to Peer Perform from Underperform at Wolfe Research
12/23/19
Fly Intel: Top five analyst actions
CAT Caterpillar
$115.28 /

+1.26 (+1.11%)

04/27/20
Fly Intel: Top five analyst downgrades
04/27/20 Morgan Stanley
Caterpillar downgraded to Underweight on construction risks at Morgan Stanley
04/27/20 Morgan Stanley
Caterpillar downgraded to Underweight from Equal Weight at Morgan Stanley
04/13/20
Fly Intel: Top five analyst downgrades
On The Fly
Fly Intel: After-Hours Movers » 19:10
04/27/20
04/27
19:10
04/27/20
19:10
FFIV

F5 Networks

$130.95 /

+3.62 (+2.84%)

, KDP

Keurig Dr Pepper

$25.80 /

-0.53 (-2.01%)

, PKG

Packaging Corp.

$90.36 /

+4.2 (+4.87%)

, AMKR

Amkor Technology

$10.18 /

+0.78 (+8.30%)

, TCF

TCF Financial

$25.56 /

+2.05 (+8.72%)

, NXPI

NXP Semiconductors

$97.16 /

+2.78 (+2.95%)

, CGNX

Cognex

$49.91 /

+1.115 (+2.29%)

, PI

Impinj

$20.39 /

-0.29 (-1.40%)

, BRO

Brown & Brown

$35.80 /

+1.04 (+2.99%)

, AVT

Avnet

$29.41 /

+1.26 (+4.48%)

, QTNT

Quotient

$7.56 /

+1.07 (+16.49%)

, MRNA

Moderna

$48.06 /

-2.43 (-4.81%)

, PCTY

Paylocity

$93.05 /

+4.675 (+5.29%)

, FOXA

Fox Corp.

$26.41 /

+1.61 (+6.49%)

, CLB

Core Laboratories

$15.47 /

+0.495 (+3.31%)

, MDP

Meredith

$12.53 /

+1.1 (+9.62%)

, LH

LabCorp

$178.79 /

+15.2 (+9.29%)

, GAIA

Gaia

$10.16 /

+0.57 (+5.94%)

, HLIT

Harmonic

$6.53 /

-0.16 (-2.39%)

, SANM

Sanmina

$27.86 /

+1.23 (+4.62%)

, LRN

K12

$25.13 /

+0.51 (+2.07%)

, UHS

Universal Health

$105.13 /

+3.6 (+3.55%)

, CE

Celanese

$82.88 /

+4.24 (+5.39%)

, FIX

Comfort Systems USA

$33.21 /

+2.16 (+6.96%)

, IMMU

Immunomedics

$28.32 /

-0.11 (-0.39%)

Check out this evening's…

Open Full Text

ShowHide Related Items >><<
FFIV F5 Networks
$130.95 /

+3.62 (+2.84%)

04/28/20 Goldman Sachs
F5 Networks upgraded to Neutral from Sell at Goldman Sachs
04/28/20 JPMorgan
F5 Networks price target raised to $145 from $138 at JPMorgan
04/28/20 Credit Suisse
F5 Networks price target lowered to $151 from $156 at Credit Suisse
04/28/20 Nomura Instinet
F5 Networks price target raised to $165 from $145 at Nomura Instinet
KDP Keurig Dr Pepper
$25.80 /

-0.53 (-2.01%)

04/01/20 Goldman Sachs
Keurig Dr Pepper resumed with a Neutral at Goldman Sachs
03/05/20 BofA
Mondelez could sell Keurig Dr Pepper shares to fund M&A, says BofA
02/24/20
Fly Intel: Top five analyst upgrades
02/24/20 Morgan Stanley
Morgan Stanley upgrades Keurig Dr Pepper to Equal Weight after underperformance
PKG Packaging Corp.
$90.36 /

+4.2 (+4.87%)

04/20/20 Argus
Packaging Corp. downgraded to Hold from Buy at Argus
04/20/20 Argus
Packaging Corp. downgraded to Hold from Buy at Argus
04/09/20 KeyBanc
Packaging Corp. price target lowered to $79 from $89 at KeyBanc
04/07/20 Goldman Sachs
Goldman cuts paper and packaging estimates, prefers Ball and Graphic Packaging
AMKR Amkor Technology
$10.18 /

+0.78 (+8.30%)

04/28/20 Credit Suisse
Amkor Technology downgraded to Neutral from Outperform at Credit Suisse
03/17/20 Sidoti
Amkor Technology initiated with a Buy at Sidoti
10/29/19
Fly Intel: Top five analyst upgrades
10/29/19 Deutsche Bank
Amkor Technology price target raised to $12 from $8 at Deutsche Bank
TCF TCF Financial
$25.56 /

+2.05 (+8.72%)

04/17/20 Wedbush
TCF Financial upgraded to Outperform from Neutral at Wedbush
04/17/20 Wedbush
TCF Financial upgraded to Outperform from Neutral at Wedbush
03/10/20
Fly Intel: Top five analyst upgrades
03/10/20 UBS
TCF Financial upgraded to Buy from Neutral at UBS
NXPI NXP Semiconductors
$97.16 /

+2.78 (+2.95%)

04/13/20 Morgan Stanley
Morgan Stanley downgrades Texas Instruments to Underweight on gross margins risk
04/13/20 Evercore ISI
NXP Semiconductors downgraded to In Line from Outperform at Evercore ISI
04/08/20 Stifel
NXP Semiconductors price target lowered to $90 from $109 at Stifel
04/08/20 Mizuho
NXP Semiconductors price target lowered to $126 from $140 at Mizuho
CGNX Cognex
$49.91 /

+1.115 (+2.29%)

04/28/20 Raymond James
Cognex price target raised to $60 from $48 at Raymond James
03/23/20 Morgan Stanley
Morgan Stanley cuts Multi-Industry estimates, shakes up ratings with 7 changes
03/23/20 Morgan Stanley
Cognex downgraded to Underweight from Equal Weight at Morgan Stanley
12/12/19 UBS
Cognex initiated with a Neutral at UBS
PI Impinj
$20.39 /

-0.29 (-1.40%)

04/28/20 Needham
Impinj price target raised to $25 from $19 at Needham
04/28/20 Canaccord
Impinj price target lowered to $35 from $40 at Canaccord
04/27/20 Piper Sandler
Impinj price target lowered to $29 from $44 at Piper Sandler
03/10/20 Morgan Stanley
Morgan Stanley lowers semiconductor estimates to reflect COVID-19 disruption
BRO Brown & Brown
$35.80 /

+1.04 (+2.99%)

01/29/20 RBC Capital
Brown & Brown price target raised to $42 from $38 at RBC Capital
01/29/20 SunTrust
Brown & Brown price target raised to $52 from $46 at SunTrust
01/15/20 SunTrust
Brown & Brown price target raised to $46 from $42 at SunTrust
12/05/19
Fly Intel: Top five analyst upgrades
AVT Avnet
$29.41 /

+1.26 (+4.48%)

04/28/20 Wells Fargo
Avnet price target raised to $27 from $22 at Wells Fargo
04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Loop Capital
Avnet initiated with a Hold at Loop Capital
04/23/20 Loop Capital
Avnet initiated with a Hold at Loop Capital
QTNT Quotient
$7.56 /

+1.07 (+16.49%)

MRNA Moderna
$48.06 /

-2.43 (-4.81%)

04/21/20 Oppenheimer
Moderna CMV vaccine candidate development reasonable, says Oppenheimer
04/17/20 Piper Sandler
Moderna price target raised to $57 from $34 at Piper Sandler
04/15/20 Roth Capital
Moderna price target raised to $41 from $33 at Roth Capital
04/15/20 Roth Capital
Moderna price target raised to $41 from $33 at Roth Capital
PCTY Paylocity
$93.05 /

+4.675 (+5.29%)

04/16/20
Fly Intel: Top five analyst downgrades
04/16/20 Stifel
Paylocity downgraded to Hold from Buy at Stifel
04/15/20 Stifel
Paylocity downgraded to Hold from Buy at Stifel
03/27/20 SunTrust
Paylocity price target lowered to $115 from $162 at SunTrust
FOXA Fox Corp.
$26.41 /

+1.61 (+6.49%)

04/27/20 RBC Capital
Fox Corp. initiated with an Outperform at RBC Capital
04/23/20 Evercore ISI
Fox Corp. downgraded to In Line from Outperform at Evercore ISI
04/13/20 Citi
Fox Corp. resumed with a Neutral at Citi
04/08/20 Societe Generale
Fox Corp. upgraded to Hold from Sell at Societe Generale
CLB Core Laboratories
$15.47 /

+0.495 (+3.31%)

04/13/20 Scotiabank
Core Laboratories upgraded to Outperform from Sector Perform at Scotiabank
03/09/20 BofA
Core Laboratories downgraded to Underperform from Buy at BofA
03/09/20 Evercore ISI
Core Laboratories downgraded to In Line from Outperform at Evercore ISI
01/30/20 Johnson Rice
Core Laboratories reinstated with a Buy at Johnson Rice
MDP Meredith
$12.53 /

+1.1 (+9.62%)

03/06/20 Benchmark
Meredith dividend looks 'very safe,' says Benchmark
01/07/20 Citi
Citi makes changes to 'Value Creators' SMID Focus List
12/11/19 Guggenheim
Guggenheim says Nexstar, Gray best positioned for 'record' political cycle
11/19/19 Stephens
Meredith price target lowered to $40 from $65 at Stephens
LH LabCorp
$178.79 /

+15.2 (+9.29%)

04/27/20
Fly Intel: Top five analyst upgrades
04/27/20 Wolfe Research
LabCorp upgraded to Peer Perform from Underperform at Wolfe Research
04/27/20 Citi
LabCorp upgraded to Buy from Neutral at Citi
04/27/20 Citi
Quest Diagnostics upgraded to Buy from Neutral at Citi
GAIA Gaia
$10.16 /

+0.57 (+5.94%)

04/28/20 Lake Street
Gaia Q1 in line when excluding live events, says Lake Street
04/28/20 B. Riley FBR
Gaia weaker than expected Q1 not thesis changing, says B. Riley FBR
02/25/20 B. Riley FBR
Gaia price target lowered to $17 from $20 at B. Riley FBR
08/06/19 Lake Street
Gaia price target lowered to $15 from $20 at Lake Street
HLIT Harmonic
$6.53 /

-0.16 (-2.39%)

04/14/20 JPMorgan
Harmonic initiated with an Overweight at JPMorgan
07/10/19 Stifel
Harmonic price target raised to $10 from $7 at Stifel
06/14/19
Fly Intel: Top five analyst upgrades
06/14/19 Raymond James
Harmonic upgraded to Outperform after multi-year transition at Raymond James
SANM Sanmina
$27.86 /

+1.23 (+4.62%)

02/13/20 Citi
Cisco results slightly negative for EMS companies, says Citi
11/14/19 Citi
Cisco results negative for electronics manufacturing services, says Citi
LRN K12
$25.13 /

+0.51 (+2.07%)

01/28/20 Barrington
K12 price target lowered to $30 from $40 at Barrington
01/28/20 BMO Capital
K12 price target lowered to $23 from $27 at BMO Capital
08/13/19 William Blair
William Blair starts Chegg, K12 with Outperform ratings
08/12/19 William Blair
K12 initiated with an Outperform at William Blair
UHS Universal Health
$105.13 /

+3.6 (+3.55%)

04/28/20 Citi
Universal Health price target lowered to $128 from $157 at Citi
03/26/20 JPMorgan
Channel checks suggest hospital total revenues down 40%-60%, says JPMorgan
03/23/20 BofA
Universal Health downgraded to Neutral on Vegas recession risk at BofA
03/23/20 BofA
Universal Health downgraded to Neutral from Buy at BofA
CE Celanese
$82.88 /

+4.24 (+5.39%)

04/09/20 JPMorgan
JPMorgan downgrades Celanese to Neutral, sees better value in Eastman
04/09/20 BMO Capital
Celanese price target lowered to $100 from $123 at BMO Capital
04/09/20 Citi
Citi upgrades Nutrien to Buy, recommends pair trade with Mosaic
04/09/20 JPMorgan
Celanese downgraded to Neutral from Overweight at JPMorgan
FIX Comfort Systems USA
$33.21 /

+2.16 (+6.96%)

04/20/20 Sidoti
Comfort Systems USA downgraded to Neutral from Buy at Sidoti
03/11/20 Sidoti
Comfort Systems USA upgraded to Buy from Neutral at Sidoti
10/28/19 DA Davidson
Comfort Systems USA price target raised to $60 from $52 at DA Davidson
07/29/19 DA Davidson
Comfort Systems USA upgraded to Buy from Neutral at DA Davidson
IMMU Immunomedics
$28.32 /

-0.11 (-0.39%)

04/24/20
Fly Intel: Top five analyst upgrades
04/23/20 Goldman Sachs
Immunomedics upgraded to Neutral from Sell at Goldman Sachs
04/23/20 Wells Fargo
Immunomedics price target raised to $41 from $34 at Wells Fargo
04/23/20 Guggenheim
Immunomedics price target raised to $39 from $35 at Guggenheim
  • 29
    Apr
Hot Stocks
Quotient up 20% at $9.10/shr after disclosing 'strong data' for COVID test  16:53
04/27/20
04/27
16:53
04/27/20
16:53
QTNT

Quotient

$7.56 /

+1.07 (+16.49%)

 

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.